Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staccato Alprazolam in epilepsy with predictable seizure pattern
NCT03478982Phase 2Completed
- Sponsor
- Engage Therapeutics
- Start
- Mar 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of alprazolam in epilepsy, sponsored by Engage Therapeutics. Started Mar 2018; status: completed.
02
Drugs
alprazolam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT03478982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03478982.